AIkido Pharma Inc (AIKI)

[Viewmont]

Something's happening with AIKI. Going up!

[Viewmont]

Went to 1.70, now coming back up for more!

[weedtrader420]

WOW!

[glens0]

1.61

[Viewmont]

AIKI @ $1.67 pre market. NICE!

[TrendTrade2016]

AIKI IS GARBAGE STAY AWAY!!

[Viewmont]

AIKI trading at $1.22 early pre-market!

[glens0]

AIKI 1.20 AH

[mick]

$AIKI THANK YOU , GOOD REPORE'

RE;
AIKI AIkido Pharma, Inc.
Shares Outstanding 34,920,200
Float 32,952,167
Insider Ownership 5.64%
Insitutional Ownership 18.10%

[glens0]

AIKI AIkido Pharma, Inc.
Shares Outstanding 34,920,200
Float 32,952,167
Insider Ownership 5.64%
Insitutional Ownership 18.10%

[Viewmont]

Nice chart georgie! Chart...http://schrts.co/nxCbhCuz

[Viewmont]

Just a reminder! AIkido Pharma Inc. Announces Key Progress in Computational Approaches to Identify Virus Treatments, Including Coronavirus
Research identified human protein complex that is important for viral replication
NEW YORK, July 9, 2020 /PRNewswire/ -- AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company") today provided an update on its effort to identify compounds to potentially address the COVID-19 pandemic. As previously announced, on April 13, 2020, AIkido executed a Master License Agreement with the University of Maryland, Baltimore ("UMB"), covering certain antiviral compounds discovered by UMB.

Recently, the researchers at UMB, including Matthew Frieman, PhD, Associate Professor of Microbiology and Immunology at the University of Maryland School of Medicine (UMSOM), Alexander MacKerell, PhD, Professor of Pharmaceutical Sciences at the University of Maryland School of Pharmacy, and Stuart Weston, PhD, Postdoctoral Fellow at UMSOM, have identified a human protein complex (called the SKI complex) that is important for replication of several viruses including Influenza, COVID-19, SARS1, MERS, SARS2, Ebola and Marburg. Using a computer modeling approach called SILCS from SilcsBio LLC, chemical compounds were identified that are predicted to bind to a pocket on a human protein in this complex. These compounds were tested for their ability to block replication of the Influenza virus in human cells, from which several active compounds were found. These compounds were then tested against the other viruses and found to block replication of these as well. Utilizing the information gleaned from this initial research and the power of the SILCS technology combined with machine learning tools, the researchers are currently identifying compounds with chemical structures similar to the active compounds and testing them to find ones that work better at blocking virus replication.

"This is encouraging progress, demonstrating the importance of machine learning to accelerate pharmaceutical research," commented Anthony Hayes, CEO of AIkido. "Legacy processes, involving manually testing potentially thousands of compounds, are slower and potentially more expensive. Utilizing a combination of a physics-based approach and machine learning, our partners are able to significantly narrow the range of potential compounds to test, accelerating efforts and significantly reducing costs. The ultimate goal is to create a new compound that blocks replication of a wide variety of viruses in humans that will be an effective drug for the treatment of known viral infections as well as those that may arise in the future."

otcmarkets.com/stock/AIKI/news/story?e&id=1641643

[Viewmont]

Nice! All 3 BUY indicators.
https://www.tradingview.com/symbols/NASDAQ-AIKI/technicals/

[Viewmont]

Let's do this! https://www.tradingview.com/symbols/NASDAQ-AIKI/technicals/

[Viewmont]

I'm looking forward to it BIG MONEY! AIKI.

[georgie18]

Your very welcome...

[weedtrader420]

We're going to make B I G money WOOHOOOOOOOOOOOOO *AIKI* <(8D)

[mick]

$AIKI https://stockcharts.com/c-sc/sc?s=AIKI&p=D&b=5&g=0&i=p81686599056&r=1595191703619

http://schrts.co/bImbybbc

[mick]

$AIKI THANK YOU
RE;
Hi mick...Hope all is well...my limited access to only 15 posts a day do not allow me to respond to many posts...sorry...

[georgie18]

Hi mick...Hope all is well...my limited access to only 15 posts a day do not allow me to respond to many posts...sorry...

[Taurus69]

$aiki $1.03 ^ 0.09 (9.57%)
Volume: 6,611,148 @07/17/20 7:59:44 PM EDT

[Viewmont]

https://investorshub.advfn.com/AIkido-Pharma-Inc-AIKI-3256/

[mick]

$AIKI , hi dare my friend

re;
AIKI...$1.03...Chart turning Very Bullish on the Consolidation Channel Breakout as the Bollinger Bands get stretched...adding on this Bullish Chart...

AIKI...tested the Break/Hold of the 200ma 3 times and failed...Monday it will Break/Hold the 200ma as well as flip the Psar to a Bullish Buy position on the Breakout...imo...we shall see...

georgie18 Saturday, 06/06/20 06:23:21 AM
Re: Citrati post# 7743 0
Post #
7744
of 7895
AIKI...73...Consolidation Channel Breakout setting up here on the Bollie Squeeze...as the Psar is ready to flip to a Bullish Buy Position...

As of May 13, 2020, there were 34,920,219 shares of the Company’s common stock issued and outstanding.

https://www.otcmarkets.com/filing/html?id=14148986&guid=JvaHUnzRuvrmGth

Chart...http://schrts.co/nxCbhCuz

Been accumulating AIKI for months also collected a nice Divvy of HOTH shares currently priced at $2.80...

[mick]

$AIKI i see $1.06 a,h, trading

re;
A good post on AIKI, $AIKI needs to break $1.12 it will be $3
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=156972130

[BluSkies]

This looks ready!

[georgie18]

AIKI...$1.03...Chart turning Very Bullish on the Consolidation Channel Breakout as the Bollinger Bands get stretched...adding on this Bullish Chart...

AIKI...tested the Break/Hold of the 200ma 3 times and failed...Monday it will Break/Hold the 200ma as well as flip the Psar to a Bullish Buy position on the Breakout...imo...we shall see...

georgie18 Saturday, 06/06/20 06:23:21 AM
Re: Citrati post# 7743 0
Post #
7744
of 7895
AIKI...73...Consolidation Channel Breakout setting up here on the Bollie Squeeze...as the Psar is ready to flip to a Bullish Buy Position...

As of May 13, 2020, there were 34,920,219 shares of the Company’s common stock issued and outstanding.

https://www.otcmarkets.com/filing/html?id=14148986&guid=JvaHUnzRuvrmGth

Chart...http://schrts.co/nxCbhCuz

Been accumulating AIKI for months also collected a nice Divvy of HOTH shares currently priced at $2.80...

[Viewmont]

http://schrts.co/bImbybbc

[Viewmont]

Great sign, going higher after hours.

[BluSkies]

This looks strong!

[Viewmont]

Then we're looking at big $$$'s...

[Viewmont]

Yes hope so. We need some major news like a drug approval.

[weedtrader420]

Hopefully this thing goes up in after-hours big time.

[Viewmont]

Closed $1.03. Closing above $1 is a good sign to upside. IMO.

[glens0]

Thank you I feel the same about AIKI. That’s why I bought in. Good trading to you

[weedtrader420]

Double our money next week probably triple have a good weekend *AIKI* my play of the week next week

[glens0]

A good post on AIKI, "$AIKI needs to break $1.12 it will be $3
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=156972130

[Viewmont]

AIKI wants to move past the $1 mark.

[glens0]

AIKI back up over $1

[weedtrader420]

AIKI will move up fast to $2

[weedtrader420]

AIKI $4 TARGET PRICE WOOHOOOOOOOOOOOOOOO

[mick]

$AIKI https://www.toppennystockmovers.com/stock-ticker/?symbols=AIKI&submit=Ticker+Search

[glens0]

AIkido Pharma, Inc. Shares Outstanding 34,920,200 Float 32,952,167
Insider Ownership 5.64%
Insitutional Ownership 18.10%
?

[mick]

$AIKI THANK YOU VERY MUCH

RE;
Picked up a few shares. Read this post.
$AIKI just added 7,777 to my 27,777 under .90 -- Got a feeling we see $3's Plus soon !!! Good luck all
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=156953075

[glens0]

Picked up a few shares. Read this post.
$AIKI just added 7,777 to my 27,777 under .90 -- Got a feeling we see $3's Plus soon !!! Good luck all
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=156953075

[mick]

$AIKI Alkido Pharma Inc (AIKI)
1.0008 ? 0.1083 (12.13%)
Volume: 11,285,444 @07/16/20 1:44:22 PM EDT
Bid Ask Day's Range
1.0 1.01 0.8631 - 1.05
AIKI Detailed Quote

[mick]

$AIKI VOLUME ALERT !!!!!

[mick]

$AIKI READING

RE;
NEW YORK, July 9, 2020 /PRNewswire/ -- AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company") today provided an update on its effort to identify compounds to potentially address the COVID-19 pandemic.

As previously announced, on April 13, 2020, AIkido executed a Master License Agreement with the University of Maryland, Baltimore ("UMB"), covering certain antiviral compounds discovered by UMB.

Recently, the researchers at UMB, including Matthew Frieman, PhD, Associate Professor of Microbiology and Immunology at the University of Maryland School of Medicine (UMSOM), Alexander MacKerell,

PhD, Professor of Pharmaceutical Sciences at the University of Maryland School of Pharmacy, and Stuart Weston, PhD, Postdoctoral Fellow at UMSOM, have identified a human protein complex
(called the SKI complex) that is important for replication of several viruses including
Influenza, COVID-19, SARS1, MERS, SARS2, Ebola and Marburg.

Using a computer modeling approach called SILCS from SilcsBio LLC, chemical compounds were identified that are predicted to bind to a pocket on a human protein in this complex.

These compounds were tested for their ability to block replication of the Influenza virus in human cells, from which several active compounds were found.

These compounds were then tested against the other viruses and found to block replication of these as well.

Utilizing the information gleaned from this initial research and the power of the SILCS technology combined with machine learning tools,

the researchers are currently identifying compounds with chemical structures similar to the active compounds and testing them to find
ones that work better at blocking virus replication.

"This is encouraging progress,
demonstrating the importance of machine learning to accelerate pharmaceutical research," commented Anthony Hayes,
CEO of AIkido.

"Legacy processes, involving manually testing potentially thousands of compounds, are slower and potentially more expensive.

Utilizing a combination of a physics-based approach and machine learning, our partners are able to significantly narrow the range of potential compounds to test,
accelerating efforts and significantly reducing costs.


The ultimate goal is to create a new compound that blocks replication
of a wide variety of viruses in humans that will be an effective drug for the treatment of known viral infections as well as those that may arise in the future."

[mick]

$AIKI https://www.barchart.com/stocks/quotes/AIKI/cheat-sheet

[Viewmont]

Something's brewing at AIKI, insiders must have some info maybe?

[BluSkies]

AIKI !!!!!!!!!